Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ulcerative Colitis
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Double (Participant, Care Provider)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04883840
- Collaborators
- Vlaams Instituut Biotechnologie (VIB)
- Investigators
- Principal Investigator: Severine Vermeire, MD & PhD KU/UZ Leuven Study Director: Jeroen Raes, PhD KU Leuven/VIB
Get Well Soon